EarlyNarratives
Pricing
Start free trialSign in
Start free trialSign in
Today's Brief

Updated daily.

Get the free BIOTECH brief in 5 minutes.

A free daily and weekly email that tells you what changed, what is noise, and where to verify it at the source.

  • Start with the short list before you open another feed.
  • See what is continuing versus what is only today's spike.
  • Open the original sources in one click when you want to verify.
Free daily + weekly email
Read today's brief

Free by email: Today’s Brief (daily) + This Week’s Brief (weekly). Upgrade later for archive, alerts, search, exports, API, and workflow.

Get tomorrow's brief by email

One field, compact consent, daily + weekly by default.

Free by email: Today’s Brief.
Please confirm consent to continue.
Add your email to continue.
How it worksOpen featured signal
What you would receive
Featured now

Advances in protein function prediction integrating sequence, structure, and language models

Recent research introduces innovative computational frameworks that enhance protein function prediction by integrating protein sequence, structural data, and natural l...

Why now: Recent advances in protein language models and AlphaFold structure predictions enable novel integrative approaches.

  • ProtBLIP2-SST
    Protein function prediction via BLIP2 with sequence, structure, and text
  • biorxiv.org
    ProtPen combines sequence- and structure-based approaches to facilitate protein...
  • ProtAug
    An empirical investigation of pLM-guided data augmentation for protein...
All source links included.
Open today's sampleBrowse signals
Read today's briefBrowse signals
Today’s strongest item first

The homepage leads with an editorially featured signal alongside the open brief, while current signals stay open across the site.

Proof, not boilerplate

3 real source links are already visible in today’s public example.

Free brief before upgrade

Get the daily + weekly brief by email first. Upgrade only if you need archive, alerts, search, exports, API, and deeper workflow tools.

What lands in your free brief

Start with the brief, then drill down only on the items that matter.

Briefing item

Avere to go public via NextCure merger with licensed psoriasis drug from China

New biotech company Avere is planning to list publicly through a reverse merger with NextCure. The company has licensed rights from Chinese drugmaker Hansoh to develop a long-acting IL-23 inhibitor pill targeting psoriasis, potentially competing with established treatments like Skyrizi and Ilumya.

Why now: Avere’s planned public listing via NextCure merger is imminent, marking a key milestone for the new biotech.

CurrentSource diversity aware
Sources: 3
See details ->
Briefing item

Autonomous AI agents advance biomedical data analysis and cardiovascular model development

Recent research introduces autonomous AI agent systems that enhance biomedical discovery and clinical AI model optimization.

Why now: Biomedical datasets and AI models are growing in complexity, demanding more efficient analytical tools.

CurrentSource diversity aware
Sources: 2
See details ->
Briefing item

EMA publishes multiple new paediatric investigation plans

The European Medicines Agency (EMA) has recently published a series of new paediatric investigation plans (PIPs), reflecting ongoing efforts to ensure medicines are appropriately studied for use in children.

Why now: The recent batch of PIPs reflects ongoing regulatory activity in paediatric drug development.

CurrentSource diversity aware
Sources: 5
See details ->
How it works

Built to save you time while keeping every key point easy to verify.

Read widely

News, social, dev channels, and primary sources.

Remove duplicates

Filter rewrites, SEO clones, and repeated takes.

Group what belongs together

So you see one story, not 20 scattered posts.

Deliver the briefing

A daily scan + drill-down with source links.

See Methodology
Start free, upgrade only if you need more

Start with the free brief if you want the signal first, not an hour of scrolling. It gives you the short list, the context, and the source links in one pass.

Upgrade later only if you need memory, alerts, archive, exports, API, and recurring workflow for ongoing research work.

Why people start with the free brief
Daily brief

The 5-minute version of what genuinely changed since yesterday.

Momentum over time

See what is building, peaking, or fading across days and weeks.

Source links included

Jump to the originals when you need to verify a claim fast.

Free daily + weekly emailUpgrade only when you need full drill-down
Get the free brief
See pricingThis Week’s Brief
Product tour

A short walkthrough of the BIOTECH dashboards.